CAPTRUST FINANCIAL ADVISORS - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$42,000
-6.7%
1,201
+22.4%
0.00%
Q1 2022$45,000
-25.0%
981
+7.9%
0.00%
Q4 2021$60,000
+9.1%
909
+4.0%
0.00%
Q3 2021$55,000
-21.4%
874
+3.6%
0.00%
-100.0%
Q2 2021$70,000
-76.8%
844
-81.5%
0.00%
-66.7%
Q1 2021$302,000
-6.2%
4,557
+8.5%
0.00%
-25.0%
Q4 2020$322,000
+94.0%
4,200
+13.5%
0.00%
+33.3%
Q3 2020$166,000
+7.1%
3,700
+5.7%
0.00%0.0%
Q2 2020$155,000
+66.7%
3,5000.0%0.00%
+50.0%
Q1 2020$93,0003,5000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders